Investment in artificial intelligence (AI) is on the increase in the pharma industry due to its capacity to drive efficiencies and innovation. 1 June 2022
“We need to make sure that cancer care gets back on top of the priority list for societies.Cancer is a disease that every second person will face.and many peopl 31 May 2022
The race to meet sudden, stratospheric demand for new anti-obesity meds is hotting up, but Novo Nordisk CEO Lars Fruergaard Jørgensen takes a collegiate approac 26 May 2022
The world’s leading cancer conference kicks off in Chicago on Friday 3 June, and for many industry participants, it will be the first time they have attended a 25 May 2022
An Expert View from Robert Wessman, chairman and CEO at global pharmaceutical company Alvogen, and founder and chairman at biopharma specialist, Alvotech. 25 May 2022
In the USA and in Europe, interest in the potential for artificial intelligence to transform different aspects of the life sciences industry is at an all time h 12 May 2022
For researchers unaffiliated with an academic library, it can be hard to find, organize, and share scientific papers. Can a new tool address this gap? 12 May 2022
It’s just got tougher for biotech companies – especially those at an early-stage where risk is greater – to access the talent essential to develop a successful 9 May 2022
USA-based Insmed (NASDAQ CM: INSM) is a biopharmaceutical company on the development and commercialization of novel, targeted inhaled therapies for patients with serious rare diseases.
Sign up to receive email updates Join industry leaders for a daily roundup of biotech & pharma news